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Having been involved in meat and food animal research for a good part of my career, I am aware of the opportunities biotechnology provides 
in improving the health of food animals and the safety of the meat supply.
As the new administrator of the U.S. Department of Agriculture, Food Safety 
and Inspection Service (FSIS), I am also aware of the responsibilities we have 
to ensure the safety of food produced through animal biotechnology. In this 
paper I will present my perspectives on animal biotechnology by discussing 
two broad areas. First, the opportunities biotechnology provides in making 
food safer, and second, the regulatory implications of the new technologies 
as they relate to the meat and poultry supply.
OPPORTUNITIES TO PRODUCE SAFER FOODS
The Food Safety Inspection Service is a public health agency dedicated to en-
suring the safety of the meat and poultry supply. For that reason, any new 
technology that offers the opportunity to fulfill that mission more effect-
ively and efficiently is of interest to us. While we are addressing the issue of 
transgenic animals, we are also looking at products such as bioengineered 
vaccines, bioengineered pharmaceuticals and diagnostic tests. All of these 
will have a long-term impact on animal health and food safety. Biotechnol-
ogy offers a number of new tools that will improve the health of food ani-
mals. Genetically engineered vaccines may confer immunity more safely and 
efficaciously than traditional vaccines. With genetically engineered vaccines 
we can differentiate whether the animal is vaccinated or infected—an impor-
tant distinction in the fight to control and eradicate animal diseases.
One North Carolina firm recently developed a method of vaccinating 
chickens inside the shell—even before they hatch. While FSIS does not use 
these vaccines or regulate them, they affect our mission by improving the 
health of animals coming to slaughter.
Other tools, such as improved diagnostic tests, are of direct value to us 
in the meat and poultry inspection program. For instance, researchers with 
USDA’s research arm, the Agricultural Research Service (ARS), are develop-
ing a recombinant antigen for the serodiagnosis of bovine cysticercosis.We 
hope to be able to use this test in the inspection program in the future.
Biotechnology also offers opportunities to improve the microbiological 
safety of meat and poultry products—our number one priority. In our labo-
ratories DNA probes are being used for detection of Salmonella in cooked, 
ready-to-eat meat and poultry products. We are working to integrate similar 
DNA probes for Listeria monocytogenes and Campylobacter into our program 
in the near future. These tests provide advantages in terms of reducing the 
time needed to get results and greater specificity in identifying organisms.
Another way to improve microbial safety is by using recombinant DNA 
to produce a bacteriocin effective against specific foodborne pathogens. The 
bacteriocin could be added to processed foods to reduce spoilage in a manner 
similar to the currently approved use of nisin in cheese spreads. Other devel-
opments are on the horizon. While we are not currently using these technolo-
gies in our microbiology program, certainly the potential is there. For in-
stance, polymerase chain reaction (PCR) technology will allow us to amplify 
the genetic material from pathogens so we can detect these pathogens with-
out enrichment. This technology will also allow us to look for a specific bac-
terial genus or species and even a specific virulence gene.
Biosensors are an even newer avenue of biotechnology research. By at-
taching an antibody, enzyme or nucleic acid to an electrode, these sensors 
can be used to detect a foodborne pathogen or antibiotic. They have the po-
tential to make shelf life predictions for chilled meat by detecting glucose 
(an indicator of microbial spoilage flora) at the surface of the meat. While de-
tection is important, the ultimate goal is to prevent contamination in the 
first place. That is why we hope to see future research directed towards using 
genetic alteration to produce meat and poultry resistant to pathogenic 
microbes such as Salmonella.
While diagnostic tests that are faster and more effective is a great advan-
tage, producing disease-resistant animals is equally important. For instance, 
ARS has demonstrated that it is possible to identify swine with a genotype 
that is resistant to trichinosis. With further research, this genotype could be 
incorporated into domestic swine populations—conferring trichinosis im-
munity to all future generations of swine.
At Texas A&M, site of NABC 4, animal geneticists Jerry Taylor and Scott 
Davis are working on a project funded by the U.S. Agency for International 
Development to determine if individual genes in goats are associated with re-
sistance to Haemonchus contortus, a parasitic disease that affects ruminants 
throughout the world. While this specific study is more applicable to Third 
World countries, it certainly has relevance for domestic animal production.
If a genetic basis for resistance can be incorporated into livestock produc-
tion, we can produce healthier animals and reduce the need for animal drugs.
There are also other possible benefits aside from disease resistance that 
may be realized through genetic modification of animals. Some of these
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possibilities include:
—animals with leaner meat;
—animals that use feed more efficiently;
—animals with better growth features; and
—animals that manufacture biopharmaceuticals for human or animal therapy. 
The potential benefits from genetically modified animals appears to be in-
creasing all the time.
REGULATION OF TRANSGENIC ANIMALS
Certainly, these new products of biotechnology such as vaccines, diagnostic 
tests and disease-resistant animals interest us as ways to make the meat and 
poultry supply safer. We also have another role—to ensure that transgenic 
animals produced through biotechnology are safe for human consumption. 
For purposes of this paper, transgenic animals are animals whose genetic 
composition has been changed by introducing selected genes from other sources 
into the line from which the animal is derived.
Food-producing animals involved in transgenic animal experiments are 
currently considered experimental under existing FSIS regulations that affect 
the meat and poultry industries. The regulations define experimental animals 
as those treated with experimental drugs, chemicals or biologies. We have not 
yet approved the slaughter of any transgenic animals and are still in the pro-
cess of developing our policy. Since the field of biotechnology is changing as 
we speak, we recognize that our regulatory oversight will have to change to keep 
pace with technological advances.
In the Federal Register of June 26, 1986, the USDA, in conjunction with 
the Office of Science and Technology Policy in the Executive Office of the 
President, stated the Department’s intention to regulate foods produced by 
new methods, such as recombinant DNA techniques, within the existing statutory 
and regulatory framework. This policy is in line with President Bush’s federal 
biotechnology policy, announced in February, 1992, which emphasizes that 
federal oversight should be based on risk, not triggered simply by an innovative 
technology.
We believe the existing system will work because we plan to regulate the 
products of biotechnology, not the process itself. Our inspection program is 
now prepared to handle many diverse animals and many different product 
types. Our system can handle transgenic animals as well. Under our planned 
regulatory approach, the investigator must specifically request slaughter of 
any investigational animals involved in transgenic experiments. Whether or 
not genetic material was successfully incorporated, the following information 
must be submitted and reviewed by FSIS before the animals are presented for 
slaughter:
—species;
—genetic changes being attempted or affected;
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—technique used to introduce the genetic material;
—results of appropriate scientific methods for detection of the transgene, 
such as PCR or Southern hybridization; and 
—physical condition and appearance of the animal prior to slaughter.
In addition, for animals that have successfully incorporated the genetic ma-
terial, the following information should also be provided:
—information on the gene product;
—analytical data/results of the gene product analysis; and 
—an assessment of animal health and performance, including a veterin-
arian’s observation and examination, and any clinical laboratory data 
on the overall health of the animal.
If the information meets the criteria under the experimental animal regula-
tions, the animals would be approved for slaughter. A request for slaughter 
of these animals must be made indicating the location of slaughter. Each ani-
mal from transgenic experiments permitted for slaughter would also receive 
the required antemortem and postmortem inspection by an FSIS inspector 
and/or veterinarian. This is important because the way in which an animal 
grows and functions is a reliable indicator that the change was not detrimen-
tal to the safety of these animals. Since we will know ahead of time that the 
trans-genic animals are to be presented for slaughter, we will have the oppor-
tunity to examine their growth and general health before they reach the 
slaughterhouse.
INTERACTION WITH OTHER AGENCIES
In evaluating the food safety of transgenic animals, we would consult with 
the Food and Drug Administration (FDA), USDA’s Animal and Plant Health 
Inspection Service (APHIS), or the Environmental Protection Agency (EPA) 
before making a food safety decision.
The FDA is responsible for assuring food from species other than those 
inspected by FSIS is safe. They are also responsible for assuring that animal 
drugs are safe, effective and properly labeled, particularly with regard to the 
safety of residues remaining in the animal at slaughter. The FDA, along with 
FSIS, is charged with assuring that food additives added to meat and poultry 
products are safe for consumers. The FDA, in cooperation with state authori-
ties, also sets standards for the wholesomeness of milk. Pesticide chemicals, 
used directly on food animals or on animal feed crops, are reviewed prior to 
marketing for safety by the EPA. Finally, biologic products, such as vaccines 
and serums used in animal health programs, are subject to oversight by 
APHIS for potential food safety impacts.
To repeat, FSIS has not approved any transgenic animals for slaughter 
yet. Our policy on these animals is still being developed and will be consid-
ered ready for review as soon as FSIS has come to an understanding with FDA 
regarding jurisdictional responsibilities of the two agencies with regard to
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animal biotechnology. FSIS is planning to publish a paper entitled “Points to 
Consider” by the end of 1992 that will offer more specific guidance on the re-
quirements for slaughter of transgenic animals. In addition, we plan to have 
our entire policy reviewed by USDA’s Agricultural Biotechnology Research 
Advisory Committee (ABRAC).
I also want to emphasize that all federal agencies involved in regulating 
biotechnology are coordinating their efforts in order to secure common 
guidelines and a clear understanding of jurisdictional responsibilities. In the 
near future evidence of this coordination as policies on various biotechnol-
ogy products emerge.
REGULATION OF NONTRANSGENIC ANIMALS FROM BIOTECHNOLOGY 
RESEARCH
Although no transgenic animals have been approved for slaughter yet, FSIS 
has authorized the slaughter of nontransgenic animals in Texas. These ani-
mals were involved in biotechnology experiments, but they were not geneti-
cally modified. These animals were slaughtered after it was ascertained that 
the criteria announced in the Federal Register notice of December 27, 1991, 
“Livestock and Poultry Connected with Biotechnology Research” (Vol 56,
No. 249) was met.
OBSTACLES TO THE USE OF BIOTECHNOLOGY IN 
ANIMAL AGRICULTURE
Progress has been made in the animal biotechnology arena and the benefits 
to animal health and food safety are evident. It will not be smooth sailing all 
the way, however. There are potential obstacles out there that must be brought 
into the open in order to address them in a constructive manner.
Consumer acceptance of the new technology is a prime example. Just 
because it is good technology does not mean consumers will accept it. All of 
us—government, academia and private industry—must work together to ad-
dress consumer concerns. At FSIS, better communication with the public 
about biotechnology as well as all other issues concerning food safety, is one 
of my major priorities. We must not wait until the questions are asked before 
we provide information. We must not wait until we are attacked to respond. 
We must be on the offense, not on the defense.
At USDA, we are developing a strategy to get information about biotech-
nology to the public with the goal of helping the public make informed deci-
sions about the products of biotechnology. Certainly, our agency will have a 
role in informing the public about our regulatory strategy regarding trans-
genic animals, but this is just a small part. We must do much more. This is es-
pecially important because we will be competing with a number of other 
groups for the public’s attention on this issue.
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Short-term, we must focus on educating U.S. policymakers about bio-
technology so they can make informed decisions on legislation and policies 
at the local level. USDA is partially funding pilot studies currently underway 
to educate local county administrators on the risks and benefits of biotech-
nology.
Long-term, we must reach the public. USDA’s Extension Service plans 
to set up focus groups with consumers to determine what types of informa-
tion the public wants and how best to provide them with that information. 
We must know our audience and we must know how to reach them.
The bottom line is this: we must stay in tune with public opinion. I urge 
you to pay close attention to a survey of consumer attitudes about biotech-
nology to be released shortly. It was conducted by North Carolina State Uni-
versity and Colorado State University and funded by USDA’s Extension Ser-
vice and North Carolina State.
While the preliminary results show overall support for the use of bio-
technology in agriculture and food production, apparently the acceptability 
of biotechnology will vary with the specific use. People are much more com-
fortable with the idea of tinkering with plants than with animals, a reflection 
of public concerns regarding the well-being of animals and moral beliefs re-
garding genetic modifications in animals.
It is also apparent that the public wants to be involved in decision-mak-
ing about biotechnology. This interest is a good sign that the public will be 
receptive to biotechnology education. That is one reason I have been so can-
did here. Not only must the public be enlightened to enable them to make in-
formed decisions about biotechnology, but they must have confidence in the 
government’s ability to regulate biotechnology. The public must believe us 
when we say these products are safe. If we do not have their confidence, use 
of the technology is threatened. That is why we must carefully develop our 
policies and involve the public in the decision-making process.
SUMMARY
In summary, biotechnology offers us many opportunities to improve agricul-
ture. I believe biotechnology will have its greatest impact on meat and poul-
try safety in two ways. First, it will provide us with diagnostic tests that can 
help us to quickly and effectively detect contamination during the food pro-
duction process.
Second, biotechnology will enable the production of healthier animals 
through improved vaccines, improved diagnostic tests and the ability to pro-
duce disease-resistant animals. Biotechnology will also potentially provide 
us with animals with leaner meat, animals that are more feed efficient and 
animals with better growth potential.
While ensuring the safety of transgenic animals will have an impact on 
FSIS, I am confident our regulatory structure is equipped to ensure the safety 
of these new animals.
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